Immuneering Ownership | Who Owns Immuneering?

Immuneering Ownership Summary

Immuneering is owned by 32.65% institutional investors, 29.12% insiders, and 38.23% retail investors. Citadel advisors is the largest institutional shareholder, holding 6.41% of IMRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.48% of its assets in Immuneering shares.

IMRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Immuneering	32.65%	29.12%	38.23%
Sector	Healthcare Stocks	47.12%	8.13%	44.75%
Industry	Biotech Stocks	45.36%	7.98%	46.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Citadel advisors	1.88M	6.41%	$2.41M
Vanguard group	1.07M	3.64%	$1.37M
Millennium management	953.23K	3.25%	$1.22M
Price t rowe associates inc /md/	859.37K	2.93%	$1.10M
Goldman sachs group	741.55K	2.52%	$949.18K
Prosight management, lp	550.00K	1.87%	$704.00K
Blackrock	533.36K	1.82%	$682.71K
Two sigma advisers, lp	248.70K	0.85%	$318.34K
Geode capital management	221.80K	0.76%	$283.98K
Two sigma investments, lp	210.03K	0.72%	$268.83K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Southport management	160.10K	0.92%	$204.93K
Prosight management, lp	550.00K	0.21%	$704.00K
Point72 asia (singapore) pte.	34.61K	0.01%	$44.30K
Xtx topco	34.16K	0.00%	$43.72K
Exchange traded concepts	74.94K	0.00%	$95.92K
Bridgeway capital management	53.95K	0.00%	$69.06K
Two sigma advisers, lp	248.70K	0.00%	$318.34K
Millennium management	953.23K	0.00%	$1.22M
Two sigma investments, lp	210.03K	0.00%	$268.83K
Citadel advisors	1.88M	0.00%	$2.41M

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	953.23K	0.00%	889.96K
Prosight management, lp	550.00K	0.21%	550.00K
Goldman sachs group	741.55K	0.00%	287.31K
Two sigma advisers, lp	248.70K	0.00%	248.70K
Two sigma investments, lp	210.03K	0.00%	210.03K

Top Sellers

Holder	Shares	% Assets	Change
Cormorant asset management, lp	-	-	-3.30M
Blackrock	533.36K	-	-843.76K
Marshall wace, llp	-	-	-384.07K
Renaissance	-	-	-349.10K
State street	69.23K	-	-307.66K

New Positions

Holder	Shares	% Assets	Change	Value
Prosight management, lp	550.00K	0.21%	550.00K	$704.00K
Two sigma advisers, lp	248.70K	0.00%	248.70K	$318.34K
Two sigma investments, lp	210.03K	0.00%	210.03K	$268.83K
Point72 asia (singapore) pte.	34.61K	0.01%	34.61K	$44.30K
Qube research	10.81K	-	10.81K	$13.84K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-4.00
Nisa investment advisors	-10.00
Farther finance advisors	-80.00
Amalgamated bank	-684.00
Royal bank of canada	-784.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	55	10.00%	9,588,469	-19.23%	32	1.98%	36	80.00%	17	-29.17%
Mar 31, 2024	50	-3.85%	11,871,552	-26.40%	40	1.34%	20	-4.76%	24	33.33%
Dec 31, 2023	52	-1.89%	16,130,676	-4.79%	55	1.58%	21	-34.38%	18	63.64%
Sep 30, 2023	53	8.16%	16,941,765	-1.90%	59	1.39%	32	-17.95%	11	83.33%
Jun 30, 2023	49	44.12%	17,269,968	46.06%	65	3.27%	39	95.00%	6	-50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	736.19K	2.48%	-
T. Rowe Price Health Sciences	509.13K	1.72%	-10.15K
Vanguard Institutional Extnd Mkt Idx Tr	289.20K	0.98%	-
Fidelity Extended Market Index	121.44K	0.41%	-6.11K
TD Health Sciences - I	75.44K	0.25%	-
NT R2000 Index Fund - NL	60.79K	0.20%	-260.00
Range Cancer Therapeutics ETF	58.35K	0.20%	-
NT R2000 Growth Index Fund - NL	52.97K	0.18%	-
Bridgeway Ultra-Small Company Market	49.85K	0.17%	-60.10K
iShares Micro-Cap ETF	49.85K	0.17%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 01, 2024	Cormorant Asset Management, LP	-	Sell	$919.50
Apr 01, 2024	Cormorant Asset Management, LP	-	Sell	$305.00
Apr 01, 2024	Cormorant Asset Management, LP	-	Sell	$1.82K
Apr 01, 2024	Cormorant Asset Management, LP	-	Sell	$30.10
Apr 01, 2024	Cormorant Asset Management, LP	-	Sell	$307.00

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	8
2024 Q1	12	5
2023 Q2	-	-
2023 Q1	-	-

IMRX Ownership FAQ

Who Owns Immuneering?

Immuneering shareholders are primarily institutional investors at 32.65%, followed by 29.12% insiders and 38.23% retail investors. The average institutional ownership in Immuneering's industry, Biotech Stocks , is 45.36%, which Immuneering falls below.

Who owns the most shares of Immuneering?

Immuneering’s largest shareholders are Citadel advisors (1.88M shares, 6.41%), Vanguard group (1.07M shares, 3.64%), and Millennium management (953.23K shares, 3.25%). Together, they hold 13.30% of Immuneering’s total shares outstanding.

Does Blackrock own Immuneering?

Yes, BlackRock owns 1.82% of Immuneering, totaling 533.36K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 682.71K$. In the last quarter, BlackRock decreased its holdings by -844K shares, a -61.27% change.

Who is Immuneering’s biggest shareholder by percentage of total assets invested?

Southport management is Immuneering’s biggest shareholder by percentage of total assets invested, with 0.92% of its assets in 160.1K Immuneering shares, valued at 204.93K$.

Who is the top mutual fund holder of Immuneering shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Immuneering shares, with 2.48% of its total shares outstanding invested in 736.19K Immuneering shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools